Merck (NYSE:MRK) reported positive Phase 3 results for tulisokibart, an anti-TL1A monoclonal antibody in moderate-to-severe ...

Researchers at Peter MacCallum Cancer Centre have developed a digital phenotype to assist with automatically identifying ...

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs for those living with the chronic, unpredictabl ...

SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or active psoriatic arthritis Approval ...

AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of children six years of age and older with ...

Good afternoon, and good evening, everyone. We hope you've had a chance to review the press release we issued after market close in the U.S. today, announcing the positive top-line results of the ...

Correspondence to Professor Jean-Frédéric Colombel, Division of Gastroenterology, Inflammatory Bowel Disease Center, Icahn School of Medicine, Mount Sinai Hospital, 17 East 102nd Street, 5th Floor, ...

aDivision of Gastroenterology, University of California, San Diego, CA, USA bDepartment of Surgery, University of California, San Diego, CA, USA cDivision of Gastroenterology, Hospital Clinic, Centro ...

Ayurveda is an ancient Indian healing system that focuses on balancing body, mind, and spirit to maintain good health. Ayurvedic treatment for ulcerative colitis includes dietary changes, yoga, and ...

Vitamin D supplementation was linked to less disease activity and inflammation in patients with inflammatory bowel disease (IBD) and promoted a more balanced immune response to the gut microbiome, new ...

The graph was created with BioRender.com. AMP, antimicrobial peptide; DSS, dextran sulfate sodium; ZO-1, zonula occludens-1. Ulcerative colitis (UC) is a chronic inflammatory bowel disease ...